BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

University of Iowa Implants State's 1st SynCardia Systems, Inc. Total Artificial Heart


7/21/2011 8:20:53 AM

TUCSON, AZ--(Marketwire - July 21, 2011) -

SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the SynCardia temporary Total Artificial Heart, announced today that University of Iowa Hospitals and Clinics -- the only comprehensive academic medical center in Iowa -- has performed the state's first implant of the Total Artificial Heart.

"This is a very efficient pump, and it does a great job pumping blood," said James Davis, MD, the cardiothoracic surgeon who implanted the device. "It's similar to a normal heart in terms of its capacity."

The 58-year-old male patient had been suffering from ischemic cardiomyopathy and was implanted with SynCardia's Total Artificial Heart on July 6. Just five days after surgery, the patient was extubated, out of bed, and walking around the ICU.

UI Hospitals and Clinics has received Institutional Review Board (IRB) approval to participate in the FDA-approved Investigational Device Exemption (IDE) clinical study of the Freedom® portable driver. Weighing 13.5 pounds, the Freedom driver is the first U.S. portable driver designed to power SynCardia's Total Artificial Heart both inside and outside the hospital.

"Our hope is that through the FDA clinical study of the Freedom portable driver, stable Total Artificial Heart patients who meet study criteria will be able to leave the hospital and wait for a matching donor heart at home with their families," said Jennifer Goerbig-Campbell, MD, a cardiologist with UI Heart and Vascular Center.

View news coverage of Iowa's 1st implant
Watch video interview with Drs. Davis and Goerbig-Campbell
Read press release from UI Hospitals and Clinics

About the SynCardia temporary Total Artificial Heart
SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart, the Total is currently approved as a bridge to transplant for people dying from end-stage biventricular heart failure. More than 900 implants account for more than 210 patient years of life.

Similar to a heart transplant, SynCardia's Total Artificial Heart replaces both failing heart ventricles and the four heart valves. It is the only device that eliminates the symptoms and source of end-stage biventricular failure. The Total Artificial Heart provides immediate, safe blood flow of up to 9.5 liters per minute through both ventricles. This high volume of safe blood flow helps speed the recovery of vital organs, helping make the patient a better transplant candidate.

In March 2011, Fast Company magazine ranked SynCardia #20 among the World's 50 Most Innovative Companies "for giving mobility to artificial heart recipients." Also in March, the longest running health and wellness series on public television, "Healthy Body, Healthy Mind," produced a 30-minute program featuring SynCardia's Total Artificial Heart. View here

For additional information, please visit: http://www.syncardia.com
or follow SynCardia on Twitter -- @SynCardia_News


Media Contact:
Don Isaacs
Vice President of Communications
SynCardia Systems, Inc.
Cell: (520) 955-0660
Email Contact



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES